Impact of Statin Therapy on Clinical Outcomes in Chronic Heart Failure Patients According to Beta-Blocker Use: Results of CIBIS II

Publisher： Karger

E-ISSN： 1421-9751|108|1|28-34

ISSN： 0008-6312

Source： Cardiology, Vol.108, Iss.1, 2006-09, pp. : 28-34

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beta‐blocker therapy and prognosis of heart failure patients with new‐onset diabetes mellitus

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 5, 2015-05 ,pp. : 550-559

John Wiley & Sons Inc

Access to resources Recommend Favorite

Trends and inequities in beta-blocker prescribing for heart failure

By Shah Sunil M   Carey Iain M   DeWilde Stephen   Richards Nicky   Cook Derek G  

British Journal of General Practice, Vol. 58, Iss. 557, 2008-12 ,pp. : 862-869

Royal College of General Practitioners

Access to resources Recommend Favorite

The Role of Beta-Blocker in Heart Failure in Adults with Congenital Heart Disease

By  

Reviews on Recent Clinical Trials, Vol. 9, Iss. 2, 2014-06 ,pp. : 64-67

Bentham Science Publishers

Access to resources Recommend Favorite

Appropriate Use of Early Beta-Blocker Therapy in Acute Coronary Syndrome

By  

Cardiology, Vol. 115, Iss. 3, 2010-02 ,pp. : 209-210

Karger

Access to resources Recommend Favorite

Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach

By Zeymer Uwe   Jüünger Claus   Zahn Ralf   Bauer Timm   Bestehorn Kurt   Senges Jochen   Gitt Anselm  

Current Medical Research and Opinion, Vol. 27, Iss. 8, 2011-08 ,pp. : 1563-1570

Informa Healthcare

Access to resources Recommend Favorite